Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NH › Laconia › NPI 1053495234
Hospital

Concord Hospital-Laconia

Concord Hospital-Laconia was paid $9.25M by Medicaid between Jan 2018 and Nov 2024, across 215 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.

33Billing provider infoCONCORD HOSPITAL-LACONIA
LACONIA, NH 03246
33aNPI1053495234assigned 10/25/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.25M
24GClaims369,597
24DCodes billed215
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Hampshire

Rank by total paid#6 of 9
Median peer was paid$10.80M
This provider vs. median0.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018106,503$2.08M
2019100,101$2.22M
202092,754$2.47M
202132,117$900K
202230,303$1.25M
20235,662$242K
2024incomplete2,157$82K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 20% 10,309 7,942 $1.81M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 18% 9,648 6,973 $1.71M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 11% 6,410 4,184 $1.01M
G0378 Hospital observation service, per hour 7.5% 2,088 773 $694K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.2% 1,972 1,464 $298K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 2.8% 26,786 13,176 $261K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.7% 3,055 2,439 $246K
70450 Computed tomography, head or brain; without contrast material 2.5% 2,316 1,594 $227K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.7% 9,986 2,605 $159K
96361 Intravenous infusion, hydration; each additional hour 1.5% 4,929 3,054 $135K
71275 Computed tomographic angiography, chest, with contrast material 1.4% 485 370 $128K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.4% 3,300 1,883 $126K
203 more codes
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.2% 3,603 $109K
72125 Computed tomography, cervical spine; without contrast material 1.1% 924 $105K
96375 Therapeutic injection; each additional sequential IV push 1.0% 4,361 $97K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 3,086 $92K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 407 $84K
J3490 Unclassified drugs <1% 27,883 $83K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 5,692 $83K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 6,991 $79K
80053 Comprehensive metabolic panel <1% 14,683 $70K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 16,576 $60K
71045 Radiologic examination, chest; single view <1% 4,450 $58K
80050 General health panel <1% 7,149 $55K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,514 $50K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,504 $50K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,367 $45K
96376 <1% 1,849 $44K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,535 $39K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 958 $39K
77067 Screening mammography, bilateral, including computer-aided detection <1% 469 $39K
76830 Ultrasound, transvaginal <1% 561 $37K
71046 Radiologic examination, chest; 2 views <1% 2,475 $37K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,190 $37K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 520 $33K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,308 $33K
J7030 Infusion, normal saline solution , 1000 cc <1% 4,391 $32K
97161 <1% 775 $29K
80061 Lipid panel <1% 2,823 $26K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 171 $25K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,331 $23K
84484 <1% 5,530 $23K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,203 $21K
97162 <1% 676 $21K
84443 Thyroid stimulating hormone (TSH) <1% 2,313 $20K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,722 $20K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 314 $19K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 1,168 $18K
J2704 Injection, propofol, 10 mg <1% 2,605 $17K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 154 $17K
82947 <1% 4,180 $17K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,634 $17K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,977 $17K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 745 $16K
97035 <1% 2,095 $16K
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,397 $14K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,842 $14K
72100 <1% 774 $14K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 680 $14K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 2,013 $14K
80048 Basic metabolic panel (calcium, ionized) <1% 3,052 $13K
83690 <1% 3,379 $13K
73030 <1% 752 $12K
83036 Hemoglobin; glycosylated (A1C) <1% 2,080 $12K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 182 $12K
93971 <1% 210 $12K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 221 $12K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 603 $12K
87186 <1% 2,367 $12K
83880 <1% 739 $11K
84702 <1% 896 $11K
73630 <1% 507 $11K
80305 <1% 2,225 $10K
87040 <1% 1,807 $10K
85610 <1% 5,775 $10K
73610 <1% 614 $10K
83605 <1% 1,683 $9K
73130 <1% 440 $8K
84703 <1% 1,591 $8K
83735 <1% 2,111 $8K
81001 <1% 4,886 $8K
87088 <1% 3,319 $8K
82728 <1% 814 $7K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 747 $7K
97803 <1% 499 $7K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,464 $7K
86803 <1% 722 $7K
87806 <1% 424 $7K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 663 $7K
J7050 Infusion, normal saline solution, 250 cc <1% 1,204 $7K
J0690 Injection, cefazolin sodium, 500 mg <1% 929 $7K
86850 <1% 964 $7K
82805 <1% 485 $6K
74018 <1% 434 $6K
81025 <1% 1,546 $6K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 158 $6K
97165 <1% 166 $6K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,638 $6K
87077 <1% 1,077 $6K
87070 <1% 1,120 $6K
73562 <1% 380 $6K
94060 <1% 172 $5K
J1170 Injection, hydromorphone, up to 4 mg <1% 856 $5K
36415 Collection of venous blood by venipuncture <1% 26,853 $5K
73560 <1% 330 $5K
85379 <1% 995 $5K
87081 <1% 1,153 $5K
76801 <1% 61 $5K
73110 <1% 232 $5K
85027 <1% 1,108 $5K
84439 <1% 680 $4K
73502 <1% 387 $4K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 949 $4K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 16 $4K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,902 $4K
86140 <1% 1,290 $4K
Q3014 Telehealth originating site facility fee <1% 853 $4K
20610 <1% 226 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,808 $3K
94726 <1% 126 $3K
81003 <1% 3,663 $3K
77063 Screening digital breast tomosynthesis, bilateral <1% 422 $3K
82607 <1% 372 $3K
87205 <1% 990 $3K
99001 <1% 512 $3K
85730 <1% 793 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,829 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 315 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 747 $2K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 147 $2K
85652 <1% 1,347 $2K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 27 $2K
82375 <1% 554 $2K
87522 Neg quan hep c or qual rna <1% 61 $2K
94729 <1% 148 $2K
86317 <1% 188 $2K
71250 <1% 13 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 75 $2K
86900 <1% 940 $2K
86901 <1% 926 $2K
93017 <1% 54 $1K
86592 <1% 424 $1K
72040 <1% 75 $1K
96367 <1% 91 $1K
90472 Immunization administration, each additional vaccine (list separately) <1% 257 $1K
J2060 Injection, lorazepam, 2 mg <1% 1,236 $1K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 20 $1K
97802 <1% 38 $1K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 694 $1K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 715 $1K
90715 <1% 158 $1K
36416 <1% 1,243 $1K
95117 <1% 265 $969.18
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 705 $941.65
88304 <1% 56 $941.58
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 15 $926.22
86618 <1% 93 $903.46
73564 <1% 34 $875.20
87340 <1% 118 $852.23
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 774 $753.47
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 13 $724.74
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 33 $698.79
83550 <1% 120 $695.03
87449 <1% 106 $676.17
83540 <1% 149 $632.33
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 86 $603.37
97113 <1% 28 $600.78
76642 <1% 39 $582.33
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 356 $485.26
83010 <1% 59 $444.00
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 58 $406.66
97166 <1% 16 $399.64
86762 <1% 37 $387.07
84403 <1% 14 $332.42
82950 <1% 81 $330.34
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 17 $323.19
87147 <1% 80 $320.65
G0008 Administration of influenza virus vaccine <1% 288 $319.43
84153 <1% 32 $304.04
87807 <1% 35 $288.30
83516 <1% 22 $287.40
S0028 Injection, famotidine, 20 mg <1% 36 $276.40
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 99 $258.72
82565 <1% 87 $255.08
72170 <1% 13 $228.28
82550 <1% 68 $226.41
84100 <1% 57 $209.45
36600 <1% 19 $202.14
86696 <1% 12 $200.75
90686 <1% 163 $192.89
J3480 Injection, potassium chloride, per 2 meq <1% 22 $157.63
80320 <1% 31 $149.00
86695 <1% 12 $136.73
80164 <1% 17 $136.51
86038 <1% 19 $129.94
J1644 Injection, heparin sodium, per 1000 units <1% 89 $129.19
84520 <1% 64 $123.98
J0780 Injection, prochlorperazine, up to 10 mg <1% 34 $106.65
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 21 $104.96
83655 <1% 12 $99.78
J1040 Injection, methylprednisolone acetate, 80 mg <1% 94 $95.92
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 81 $72.54
J1815 Injection, insulin, per 5 units <1% 27 $71.20
82043 <1% 14 $65.18
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 78 $65.14
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 18 $58.34
90674 <1% 58 $48.67
90662 <1% 47 $42.70
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 20 $41.25
J2550 Injection, promethazine hcl, up to 50 mg <1% 37 $34.91
A4565 Slings <1% 17 $27.17
85018 <1% 12 $19.41
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 25 $18.45
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 348 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 321 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSLOANE, SCOTT (CHIEF FINANCIAL OFFICER)
Parent organizationCONCORD HOSPITAL-LACONIA
Same official

Other billing entities under SLOANE, SCOTT

Full network →
ProviderLocationPaid
Concord Hospital, INC.Concord, NH$28.77M
Concord Hospital-FranklinFranklin, NH$7.28M
Concord Hospital, INC.Concord, NH$3.74M
Concord Hospital-FranklinFranklin, NH$3.61M
Concord Hospital-LaconiaLaconia, NH$2.92M
Concord Hospital-FranklinFranklin, NH$2.72M
Concord Hospital-LaconiaLaconia, NH$2.53M
Concord Hospital, INC.Concord, NH$2.48M
Concord Hospital-LaconiaLaconia, NH$109K
Concord Hospital-LaconiaLaconia, NH$16K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.